Gangolli Julian S has filed 14 insider transactions across 2 companies since March 2023.
Most recent transaction: a grant/award of 286734 shares of Outlook Therapeutics, Inc. ($OTLK) on October 01, 2025.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 1, 2025 | Outlook Therapeutics, Inc. | $OTLK | Gangolli Julian S | Director | A | Stock Option (Right to Buy) | 286734 | $0.00 | 286,734.0000 | 34,796,120 | 9999.99% | 0.82% |
| June 30, 2025 | Krystal Biotech, Inc. | $KRYS | Gangolli Julian S | Director | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 29,740,000 | 9999.99% | 0.02% |
| Oct. 1, 2024 | Outlook Therapeutics, Inc. | $OTLK | Gangolli Julian S | Not found | A | Stock Option (Right to Buy) | 71169 | $0.00 | 71,169.0000 | 18,548,813 | 9999.99% | 0.38% |
| Oct. 1, 2024 | Outlook Therapeutics, Inc. | $OTLK | Gangolli Julian S | Not found | A | Stock Option (Right to Buy) | 56636 | $0.00 | 56,636.0000 | 18,548,813 | 9999.99% | 0.31% |
| June 30, 2024 | Krystal Biotech, Inc. | $KRYS | Gangolli Julian S | Director | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 27,752,000 | 9999.99% | 0.02% |
| May 20, 2024 | Krystal Biotech, Inc. | $KRYS | Gangolli Julian S | Director | S | Common Stock | 7090 | $164.34 | 1,980.0000 | 27,752,000 | 78.17% | 0.03% |
| May 20, 2024 | Krystal Biotech, Inc. | $KRYS | Gangolli Julian S | Director | M | Common Stock | 20000 | $22.75 | 20,000.0000 | 27,752,000 | 9999.99% | 0.07% |
| May 20, 2024 | Krystal Biotech, Inc. | $KRYS | Gangolli Julian S | Director | S | Common Stock | 10930 | $163.71 | 9,070.0000 | 27,752,000 | 54.65% | 0.04% |
| May 20, 2024 | Krystal Biotech, Inc. | $KRYS | Gangolli Julian S | Director | S | Common Stock | 1980 | $165.76 | 0.0000 | 27,752,000 | 100.00% | 0.01% |
| May 20, 2024 | Krystal Biotech, Inc. | $KRYS | Gangolli Julian S | Director | M | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 27,752,000 | 100.00% | 0.07% |
| March 7, 2024 | Outlook Therapeutics, Inc. | $OTLK | Gangolli Julian S | Not found | A | Stock Option (Right to Buy) | 94441 | $0.00 | 94,441.0000 | 13,012,833 | 9999.99% | 0.73% |
| Oct. 4, 2023 | Outlook Therapeutics, Inc. | $OTLK | Gangolli Julian S | Director | A | Stock Option (Right to Buy) | 370282 | $0.00 | 370,282.0000 | 12,508,817 | 9999.99% | 2.96% |
| June 30, 2023 | Krystal Biotech, Inc. | $KRYS | Gangolli Julian S | Director | A | Stock Option (Right to Buy) | 6800 | $0.00 | 6,800.0000 | 25,492,000 | 9999.99% | 0.03% |
| March 29, 2023 | Outlook Therapeutics, Inc. | $OTLK | Gangolli Julian S | Director | A | Stock Option (Right to Buy) | 41065 | $0.00 | 41,065.0000 | 227,410,533 | 9999.99% | 0.02% |